Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Biomerica (BMRA) Gross Profit (2016 - 2026)

Biomerica's Gross Profit history spans 17 years, with the latest figure at -$44000.0 for Q1 2026.

  • On a quarterly basis, Gross Profit fell 331.58% to -$44000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $187000.0, a 75.56% decrease, with the full-year FY2025 number at $498000.0, down 18.49% from a year prior.
  • Gross Profit hit -$44000.0 in Q1 2026 for Biomerica, down from $51000.0 in the prior quarter.
  • Over the last five years, Gross Profit for BMRA hit a ceiling of $1.7 million in Q1 2022 and a floor of -$244000.0 in Q2 2025.
  • Historically, Gross Profit has averaged $251777.1 across 5 years, with a median of $120000.0 in 2023.
  • Biggest five-year swings in Gross Profit: skyrocketed 4710.87% in 2022 and later plummeted 1320.0% in 2025.
  • Tracing BMRA's Gross Profit over 5 years: stood at $352000.0 in 2022, then dropped by 7.67% to $325000.0 in 2023, then surged by 34.46% to $437000.0 in 2024, then crashed by 88.33% to $51000.0 in 2025, then plummeted by 186.27% to -$44000.0 in 2026.
  • Business Quant data shows Gross Profit for BMRA at -$44000.0 in Q1 2026, $51000.0 in Q4 2025, and $424000.0 in Q3 2025.